Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere. . . . → Read More: Infographic – Q3 2021 Venture Funds Continue Banner Year
|
|||||
       
  |
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call 
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M 
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals 
NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September. . . . → Read More: Infographic – Cruising Biotech Index Takes Late Dip 
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, university, venture capital 
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund. . . . → Read More: Seed Stage Investors Raise $450M for New Fund Comments are closed Finance biotechnology, computer science, engineering, entrepreneurs, equity, investment, Israel, life sciences, physical sciences, software, venture capital 
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, Europe, investment, IPO, merger, pharmaceuticals 
Despite an increase in venture investment dollars so far this year, investments in new companies started by women continue to lag behind. . . . → Read More: Infographic – Few Venture Dollars for Women Founders One comment - (Comments are closed) Finance economics, entrepreneurs, equity, investment, statistics, venture capital 
A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds. . . . → Read More: Off-the-Shelf Stem Cell Company Forms, Gains $72M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, stem cells, university, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
